Nura Bio
Latest round
- Series B
Last raised
- Jun 2026
Total raised
- $215M
Investors
- 4
About Nura Bio
Founded in 2018 and headquartered in San Francisco, US, Nura Bio Inc. specializes in neuroprotective medications. Nura Bio has completed a total of 3 deals, with the most recent deal dated September 17, 2024.Nura Bio™ develops neuroprotective medicines designed to treat various neurological diseases by targeting critical biological pathways related to axon degeneration and neuroimmune regulation. Their product offerings are rooted in extensive scientific research, promising advancements in treating disorders such as Alzheimer’s disease, multiple sclerosis, and amyotrophic lateral sclerosis (ALS).Nura Bio generates revenue through the commercialization of its proprietary neuroprotective medicines, developed via rigorous scientific methodologies and clinical trials. Revenue streams include partnerships with healthcare providers and pharmaceutical companies, as well as potential licensing agreements for flagship products. The company employs a partnership model focusing on both direct-to-consumer sales and B2B collaborations, tailoring pricing plans to meet the needs of patients, healthcare systems, and research organizations. In June 2026, Nura Bio Inc.
Who invested in Nura Bio
4 investors across 3 rounds
See all investors in Nura Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nura Bio
Who invested in Nura Bio?
Nura Bio has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nura Bio raised?
Nura Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Nura Bio last raise money?
Nura Bio's most recent round on record is a Series B, in Jun 2026.
What does Nura Bio do?
Founded in 2018 and headquartered in San Francisco, US, Nura Bio Inc.
Where is Nura Bio headquartered?
Nura Bio is headquartered in San Francisco, US.
Which VCs invest in companies like Nura Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nura Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Nura Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.